AM-PHARMA

Dead / Abandoned — Abandoned — failure to respond (as of 19 Jan 2023)

What this means for you

This application is over — abandoned 09 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number
79311483
Mark type
Stylized text
Filed
28 Jan 2021
Abandoned
09 Jan 2023
Attorney of record
James C. Watson

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical, medical and veterinary preparations for the treatment and prevention of kidney diseases and kidney dysfunction; plasters for medical purposes, adhesive bandages; disinfectants; dietary supplements for medical purposes; diagnostic preparations for medical use; enzyme preparations for medical use; medicines for human use for the treatment of kidney disease and kidney dysfunction; pharmaceutical drugs for the treatment of kidney diseases and kidney dysfunction; pharmaceutical preparations to treat kidney diseases and kidney dysfunction
  • Class 042 — Scientific and technological services: Scientific and technological services, as well as research and design related thereto , in the field of kidney disease and kidney dysfunction; research in the scientific, technological and industrial fields in the field of kidney disease and kidney dysfunction; industrial analysis and industrial research services in the field of kidney disease and kidney dysfunction; development of technologies, diagnostics, drugs, personal care products, and devices for others in the field of kidney disease and kidney dysfunction; biotechnological research in the field of enzymatic synthesis; testing, authentication and quality control; medical and pharmaceutical research services; provision of medical and scientific research information in the field of pharmaceutical products and clinical trials; pharmaceutical research; research and development services for the pharmaceutical and biotechnology industry; pharmaceutical development of drugs; testing of pharmaceutical products; pharmaceutical drug development services; consulting in the field of pharmaceutical research; clinical research and research in the medical field relating to kidney disease and kidney dysfunction; scientific research for medical purposes, namely, conducting clinical trials; conducting clinical trials for others in the field of pharmaceutical products for the treatment of kidney disease and kidney dysfunction
  • Class 044 — Medical, beauty and agricultural services: Provision of short-term care medical services in intensive care units and hospitals; services of hygiene and beauty care for people; consultancy and information related to short-term care biopharmaceutical products provided in intensive care units and hospitals; short-term care pharmaceutical consultancy provided in intensive care units and hospitals; provision of news and information in the field of short-term care medicines provided in intensive care units and hospitals; medical services for diagnosis of diseases of the human body provided in intensive care units and hospitals

Owner

Prosecution history

  • 13 Feb 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
  • 19 Jan 2024 — FINAL DISPOSITION NOTICE SENT TO IB
  • 19 Jan 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
  • 19 Jan 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
  • 19 Jan 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
  • 19 Jan 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
  • 14 Nov 2022 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
  • 26 Oct 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
  • 26 Oct 2022 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
  • 07 Jul 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 07 Jul 2022 — NON-FINAL ACTION E-MAILED
  • 07 Jul 2022 — NON-FINAL ACTION WRITTEN
  • 01 Jun 2022 — ASSIGNED TO EXAMINER
  • 25 Mar 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 25 Mar 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE

View this trademark record on Marksy